Congress Tells FDA No on Lab Closures

Search

Topics

Links
- FDA

Case Review Form

* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of injured person
(mm-dd-yyyy):

Please describe food poisoning:

When did food poisoning occur?

Were you able to determine the food responsible for your illness?

Please describe illness resulting from food poisoning:

Other Info:

No Yes, I agree to the Parker & Waichman, LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker & Waichman, LLP monthly newsletter, InjuryAlert.

Archives

Latest Food News

Draft Guidance for Industry: Questions and Answers Regarding the Labeling of Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act: Revision 1 - This draft guidance document is intended to assist the dietary supplement industry in complying with the labeling requirements prescribed for dietary supplement manufacturers, packers, and distributors by the Dietary Supplement and Nonprescription Drug
Enhanced Aquaculture and Seafood Inspection - Report to Congress - FDA's 2008 Report to Congress on Enhanced Aquaculture and Seafood Inspection as required by the Food and Drug Administration Amendments Act of 2007 Public Law 110-85 - Section 1006.
FDA Announces Participants of Pilot Program for Third-Party Certification of Imported Aquacultured Shrimp - The U.S. Food and Drug Administration announced the participants in Phase II of its pilot program for voluntary third-party certification programs for imported aquacultured shrimp.
FDA Prevents Two Dairies from Adulterating Animal Drugs and Food - The U.S. Food and Drug Administration announced that the District Court for the District of New Mexico has enjoined Do-Rene and Clover Knolls Dairies and their owners, Douglas B. Handley and Irene Handley, from adulterating new animal drugs and introducing adulterated food into commerce. Both companies are based in Clovis, N.M.
FDA Reports Significant Progress in Protecting the Food Supply - The U.S. Food and Drug Administration today released a report on its implementation of the Food Protection Plan that was launched a year ago to protect both domestic and imported food from accidental and intentional contamination. The Plan, which outlines strategies for prevention, intervention and response, is designed to address food safety and food defense for both domestic and imported products and covers the full lifecycle of food, by encouraging the building of safety into every step of the food supply chain.
FDA Warns Consumers About Tainted Weight Loss Pills - The U.S. Food and Drug Administration is alerting consumers nationwide not to purchase or consume more than 25 different products marketed for weight loss because they contain undeclared, active pharmaceutical ingredients that may put consumers' health at risk.
FDA Warns Consumers and Retailers of Botulism Risk from Ungutted, Salt-Cured Alewives (Gaspereaux) Fish - FDA is warning retailers and food service operators not to offer for sale ungutted, salt-cured alewives (also called gaspereaux fish) from Michel and Charles LeBlanc Fisheries Ltd., CAP-PELE, New Brunswick, Canada, because the fish may contain the Clostridium botulinum toxin. Consumers should not consume the product.
Guidance for Industry: Dear Manufacturer Letter Regarding Front-of-Package Symbols - FDA is taking this opportunity to remind food manufacturers and distributors about current regulatory schemes and requirements with regard to nutrition claims in light of the expanding use in the marketplace of front-of-package symbols on food products.
Guidance for Industry: Substantiation for Dietary Supplement Claims Made Under Section 403(r)(6) of the Federal Food, Drug, and Cosmetic Act - This guidance document is intended to descrive the amount, type, and quality of evidence FDA recommends a manufacturer have to substantiate a claim under section 403(r) (6) of the Federal Food, Drug, and Cosmetic Act.

Congress Tells FDA No on Lab Closures

August 1st, 2007 admin

The Food and Drug Administration (FDA) wants to consolidate testing labs, a move that would close nearly half, but Congress has found a way to squash that plan. Last Tuesday, lawmakers on a panel investigating the FDA’s poor track record of policing food and drugs were incensed that the agency would consider closing labs at time when food poisoning reports have reached an all-time high. As it is, the existing labs are stretched to the limit, with the FDA inspecting only 1-percent of the goods under its oversight. Well, now Congress is considering a spending bill that would prohibit the FDA from closing labs. The bill withholds funds to be used for the closures unless the FDA can prove that the plan would offer American consumers more protection from tainted food or defective drugs. Despite repeated demands from Congress, the FDA has yet to prove that any lab closures would benefit the public.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.